2026 年的期刊文章 · 第 30 页

共 1756 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2026-03-16 到 2026-03-03。

按期刊、按主题看 →

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 页

JASA Testing & Uncertainty · 发表于 2026-03-16

Adaptive Selection for False Discovery Rate Control Leveraging Symmetry

Kehan Wang, Yuexin Chen, Yixin Han, Wangli Xu, Linglong Kong

摘要

Controlling the false discovery rate (FDR) in high-dimensional multiple testing has recently been advanced through mirror statistics via knockoff and data splitting. However, these approaches primarily emphasize the symmetry structure of the one-dimensional mirror statistics while inadvertently overlooking the distribution information from non-null features when determining the rejection region, potentially causing a power loss. To tackle this challenge, we present a novel framework termed symmetry-based adaptive selection (SAS), which leverages the symmetry property of the two-dimensional statistics associated with the null features to estimate the local FDR and thereby determine the rejection region. We provide theoretical evidence for the asymptotic validity of FDR control and emphasize the superior power performance of our proposed SAS. Extensive numerical results from both synthetic experiments and two real-world datasets demonstrate that the proposed SAS achieves satisfactory FDR control and significant power improvements over existing methods. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*

SiM Missing Data & Measurement Error Survival Analysis High-Dimensional · 发表于 2026-03-16,收录于 2026-09-10

Accommodating the Analysis Model in Multiple Imputation for the Weibull Mixture Cure Model: Performance Under Penalized Likelihood

Changehang Xu, Laurent Briollais, Irene L. Andrulis, Shelley B. Bull

摘要

(verbatim, in full — reproduced from the arXiv preprint version, arXiv:2507.16690; wording may differ in minor respects from the final Wiley version of record, which could not be accessed directly): "In analysis of time-to-event outcomes, a mixture cure (MC) model is preferred over a standard survival model when the sample includes individuals who will never experience the event of interest. Motivated by a cohort study of breast cancer patients with incomplete biomarkers, we develop multiple imputation (MI) methods assuming a Weibull proportional hazards (PH-MC) analysis model with multiple prognostic factors. However, for MI with fully conditional specification, an incorrectly-specified imputation model can impair accuracy of point and interval estimates. Our goal is to propose imputation models that are compatible with the Weibull PH-MC analysis models. We derive an exact conditional distribution (ECD) imputation model which involves the analysis model likelihood. Using simulation studies, we compare effect estimate bias and confidence interval (CI) coverage under alternative imputation models including the ECD model, an approximation that includes a cure indicator (cECD), and a comprehensive simple (CS) model. For robust parameter estimation in finite and/or sparse samples, we incorporate the Firth-type penalized likelihood (FT-PL) and combined likelihood profile (CLIP) methods into the MI. Compared to complete case analysis, MI with penalization reduces estimation bias and improves coverage. Although ECD and cECD perform similarly at higher event rates, ECD generates smaller bias and higher coverage at lower rates. CS has larger bias and lower coverage than ECD and cECD, but CIs are narrower than for cECD. In analyses of biomarkers and composite subtypes for prognosis studies such as in breast cancer, use of compatible imputation models and penalization methods are recommended for MC modelling in samples with low event numbers and/or with covariate imbalance.

SiM Clinical Trials · 发表于 2026-03-16

A Note on “A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design”

Silke Jörgens, Gernot Wassmer

摘要

Mehta and Kappler compare two approaches to adaptive multi‐arm multi‐stage testing: Stagewise MAMS based on the inverse normal combination test, and cumulative MAMS based on the conditional error rate approach. They show the difference in power between these approaches and conjecture as to its origin. While the results they report are well known, we would like to add a more differentiated insight into the reasons for the power difference.

JASA Longitudinal Data High-Dimensional Latent Variables & Mixtures · 发表于 2026-03-16

A Latent Variable Approach to Learning High-Dimensional Multivariate Longitudinal Data

Sze Ming Lee, Yunxiao Chen, Tony Sit

摘要

High-dimensional multivariate longitudinal data, which arise when many outcome variables are measured repeatedly over time, are becoming increasingly common in social, behavioral and health sciences. We propose a latent variable model for drawing statistical inferences on covariate effects and predicting future outcomes based on high-dimensional multivariate longitudinal data. This model introduces unobserved factors to account for the between-variable and across-time dependence and assist the prediction. Statistical inference and prediction tools are developed under a general setting that allows outcome variables to be of mixed types and possibly unobserved for certain time points, for example, due to right censoring. A central limit theorem is established for drawing statistical inferences on regression coefficients. Additionally, an information criterion is introduced to choose the number of factors. The proposed model is applied to customer grocery shopping records to predict and understand shopping behavior. *(abstract via OpenAlex)*

SiM Longitudinal Data Bayesian Methods · 发表于 2026-03-16

A Bayesian Approach for Robust Longitudinal Envelope Models

Peng Zeng, Yushan Mu

摘要

The envelope model provides a dimension‐reduction framework for multivariate linear regression. However, existing envelope methods typically assume normally distributed random errors and do not accommodate repeated measures in longitudinal studies. To address these limitations, we propose the robust longitudinal envelope model (RoLEM). RoLEM employs a scale mixture of matrix‐variate normal distributions to model random errors, allowing it to handle potential outliers, and incorporates flexible correlation structures for repeated measurements. In addition, we introduce new prior and proposal distributions on the Grassmann manifold to facilitate Bayesian inference for RoLEM. Simulation studies and real data analysis demonstrate the superior performance of the proposed method.

SMMR Bayesian Methods High-Dimensional Spatial & Time Series · 发表于 2026-03-15

Flexible Bayesian modeling of non-equidispersed counts with penalized complexity priors in disease incidence studies

Mahsa Nadifar, Hossein Baghishani, Thomas Kneib, Afshin Fallah

摘要

Counts in epidemiology often deviate from equidispersion and exhibit spatial, temporal, and nonlinear structure that the Poisson model cannot accommodate. We introduce a gamma-count structured additive regression model that strategically integrates penalized complexity priors in two critical aspects: (i) a principled penalized complexity prior on the dispersion parameter of the gamma-count distribution, which naturally shrinks toward the base Poisson model when the data support equidispersion, and (ii) scale-dependent penalized complexity hyperpriors on the smoothing variances for nonlinear, spatial, and temporal effects. By formulating the model within a latent Gaussian framework, we enable efficient approximate Bayesian inference through integrated nested Laplace approximations. Simulation studies across under-, equi-, and over-dispersed regimes show that the penalized complexity prior for dispersion parameter combined with scale-dependent hyperpriors yields accurate estimation of dispersion and smooth effects, favorable predictive scores, and robust inference. In empirical applications to larynx cancer mortality in Germany, COVID-19 incidence in Georgia (USA), and lung and bronchus cancer in Iowa (USA), the gamma-count structured additive regression model exhibits competitive or enhanced fit relative to Poisson and negative binomial counterparts, while elucidating interpretable nonlinear and spatial structures. This framework delivers robust, spatially resolved estimates of disease burden in the presence of non-equidispersion, thereby facilitating evidence-based resource allocation, epidemiological surveillance, and monitoring of health disparities, contributing to Sustainable Development Goals (SDGs) 3 (Good Health and Well-Being) and 10 (Reduced Inequalities). For geographically targeted analyses, it further supports informed decision-making in urban and community planning, aligning with SDG 11 (Sustainable Cities and Communities).

JRSSB High-Dimensional · 发表于 2026-03-13

Statistical exploration of the manifold hypothesis

Nick Whiteley, Annie Gray, Patrick Rubin-Delanchy

摘要

The manifold hypothesis is a widely accepted tenet of machine learning which asserts that nominally high-dimensional data are in fact concentrated near a low-dimensional manifold, embedded in high-dimensional space. This phenomenon is observed empirically in many real-world situations, has led to development of a wide range of statistical methods in the last few decades, and has been suggested as a key factor in the success of modern AI technologies. We show that rich and sometimes intricate manifold structure in data can emerge from a generic and remarkably simple statistical model—the latent metric space (LMS) model—via elementary concepts such as latent variables, correlation, and stationarity. This establishes a general statistical explanation for why the manifold hypothesis seems to hold in so many situations. Informed by the LMS model we derive procedures to discover and interpret the geometry of high-dimensional data, and explore hypotheses about the data-generating mechanism. These procedures operate under minimal assumptions and make use of well-known dimension reduction methods and graph-analytic algorithms.

SiM Causal Inference · 发表于 2026-03-13

Propensity Score‐Based Stratified Win Ratio for Augmented Control Designs

Yurong Chen, Yingdong Feng, Michael Sonksen, Tuo Wang, Joon Jin Song

摘要

This paper proposes a propensity score (PS)‐based stratified win ratio method to address challenges of small patient populations in clinical trials, especially for rare or pediatric diseases, by incorporating external control data. Our approach enhances traditional win ratio analysis by leveraging PS stratification to account for heterogeneity between the current and external studies. Additionally, down‐weighting based on the overlapping coefficient of PS distributions of current treatment and external control groups further mitigates the patient bias due to heterogeneity. Simulations show significant improvements in statistical power for detecting treatment effects within the composite endpoint combining continuous and time‐to‐event components, over nonborrowing and pooling methods, with utilizing Mantel‐Haenszel (MH)‐type weights achieving the highest power. The proposed methods are also applied to an amyotrophic lateral sclerosis (ALS) study incorporating the external control arm from a prior ALS trial. The proposed PS‐based stratified win ratio method thus provides a rigorous framework for borrowing external data and analyzing composite endpoints with limited patient availability.

SMMR Clinical Trials · 发表于 2026-03-13

Efficient design of partially nested randomized trials: A maximin approach

Math JJM Candel, Gerard JP van Breukelen

摘要

For two-treatment randomized trials with clustering in one of the treatment arms and a continuous outcome, designs are presented that minimize the number of subjects or the amount of research budget, when aiming for a desired power level. These designs optimize the treatment-to-control allocation ratio of study participants but also optimize the choice between the number of clusters (such as therapy groups) versus the number of persons per cluster (therapy group) in the arm with clustering. Optimal designs require prior knowledge of parameters from the analysis model, which are unknown during the design stage. We present maximin designs which address this by ensuring a pre-specified power level for plausible ranges of the unknown parameters, while maximizing the power for worst-case values of these parameters. Maximin designs are also derived when the number of clusters, or the cluster size is fixed due to practical constraints. An empirical example illustrates how to calculate sample sizes for such practical designs and shows how much these maximin designs can reduce the required research budgets compared to designs with equal subject numbers in treatment and control. A user-friendly R Shiny app facilitates these sample size calculations.

Biometrika Causal Inference Nonparametric & Semiparametric · 发表于 2026-03-13

Comparing causal parameters with many treatments and positivity violations

A McClean, Y Li, S Bae, M McAdams DeMarco, I Díaz, W Wu

摘要

Summary: Comparing outcomes across treatments is essential in medicine and public policy. To do so, researchers typically estimate a set of parameters, possibly counterfactual, each targeting adifferent treatment. Treatment-specific means are commonly used, but their identification requires a positivity assumption: every subject has a nonzero probability of receiving each treatment. This assumption is often implausible, especially when treatment can take many values. Causal parameters based on dynamic stochastic interventions offer robustness to positivity violations. However, comparing these parameters may fail to reflect the effects of the underlying target treatments because the parameters can depend on outcomes under nontarget treatments. To clarify when two parameters targeting different treatments yield a useful comparison of treatment efficacy, we propose a comparability criterion: if the conditional treatment-specific mean for one treatment is greater than that for another, then the corresponding causal parameter should also be greater. Many standard parameters fail to satisfy this criterion, but we show that only a mild positivity assumption is needed to identify parameters that yield useful comparisons. We then provide two simple examples that satisfy this criterion and are identifiable under the milder positivity assumption: trimmed and smooth-trimmed treatment-specific means with multivalued treatments. For smooth-trimmed treatment-specific means, we develop doubly robust-style estimators that attain parametric convergence rates under nonparametric conditions. We illustrate our methods with an analysis of dialysis providers in New York State.

SiM Diagnostics & Prediction · 发表于 2026-03-13

A Surrogate‐Calibrated Updating Method for Logistic Regression With Missing Covariates

Jooha Oh, Yei Eun Shin

摘要

Missing covariates are a common challenge when applying an existing logistic regression model to new or external datasets, particularly in the context of model updating. While regression calibration and model updating methods have been developed to address such partial data availability, each has limitations in terms of bias, variance, and sensitivity to model misspecification. In this study, we propose a surrogate‐calibrated updating (SCU) method that integrates calibration and updating approaches to improve the efficiency and reliability of coefficient estimation in the presence of missing covariates. The SCU method leverages surrogate covariates—variables that are routinely available across old and new datasets and correlate with the missing covariates—and applies a weighted averaging scheme that combines information from both fully observed and partially observed data sources. This approach mitigates bias while reducing variance, offering a practical and robust alternative to existing methods in population updating setting. We provide a theoretical justification and derive the corresponding estimators and variances. Simulation studies demonstrate the method's favorable performance under various scenarios, including the case with model misspecification. The SCU method is further illustrated using data from the Framingham Heart Study, where diabetes history serves as a surrogate for partially observed glucose levels in assessing cardiovascular disease risk. JEL Classification: C13, C18, C35

SiM Latent Variables & Mixtures Clinical Trials · 发表于 2026-03-12

Location‐Scale Latent Process Model for Repeated Ordinal Patient‐Reported Outcomes

Agnieszka Król, Robert Palmér, Jacob Leander, Cécile Proust‐Lima, Alexandra Jauhiainen

摘要

Patient‐reported outcomes (PROs) are collected daily in clinical trials to measure patients' quality of life, for example by capturing symptoms. These data are often reported on a small‐range ordinal scale and analyzed without consideration of their longitudinal characteristics. The emergence of electronic data collection methods for home‐based measurements has enabled routine, daily capture of various symptom scores, highlighting the need for statistical methods to analyze frequent ordinal longitudinal data. Both their mean structure over time and variability, which are known to be linked to disease progression, are of interest and can be affected by treatment. To model the dynamics of ordinal PROs, we propose a location‐scale latent process model that includes two types of variability across patients: individual underlying level flexibly modeled over time (e.g., with splines) using random effects and covariates, and individual short‐term variability with the error variance expressed as a linear structure of covariates (e.g., treatment) and a patient‐specific random intercept. The model is estimated in a maximum likelihood framework with an interface in R. The multidimensional intractable integrals in the optimization are approximated using a Quasi‐Monte Carlo method. The estimation procedure is validated by a simulation study and we apply the methodology to data from two clinical trials, one in asthma and one in chronic obstructive pulomonary disease (COPD), to evaluate the effect of treatment on the dynamics of various respiratory symptoms and their variability.

SiM Clinical Trials Causal Inference · 发表于 2026-03-12

Dynamic Borrowing With a Bias‐Tolerance Cap in Augmented Randomized Controlled Trials

Kota Sawada, Shogo Nomura, Tomohiro Shinozaki

摘要

Although randomized controlled trials (RCTs) are the gold standard for evaluating the efficacy and safety of treatments, they are challenged by cost, duration, enrollment, or ethical concerns. A possible solution is to incorporate external control data as a hybrid control group, for which various statistical methods are available. However, only a few of them account for confounding bias due to unknown/unmeasured covariates between the internal and external control data. Moreover, the amount of this potential bias cannot be measured using most existing methods without extensive simulations. Here, we propose a novel method for estimating the confounding effects of unmeasured covariates based on model‐based regression standardization, inverse probability weighting, and augmented inverse probability weighting for continuous or binary outcomes. We also propose an estimator that dynamically borrows external data and uses a weighted mean, adjusting weights according to the estimated confounding effect of unmeasured covariates. In the proposed method, the expected amount of bias can be controlled within a prespecified “bias‐tolerance cap,” which may facilitate a better discussion among stakeholders about whether an effect estimate has unacceptable bias by utilizing external control data in a planning phase. Simulations showed that the proposed method regulates bias within the tolerance cap, regardless of the magnitude of confounding by unmeasured covariates, while greatly improving power and efficiency when confounding is absent. Finally, we illustrate an applicational example of our proposed method to an actual RCT and the external control datasets for patients with advanced pancreatic cancer.

SiM Clinical Trials Bayesian Methods · 发表于 2026-03-12

Design of Bayesian Clinical Trials With Clustered Data

Luke Hagar, Shirin Golchi

摘要

In the design of clinical trials, it is essential to assess the design operating characteristics (e.g., power and the type I error rate). Common practice for the evaluation of operating characteristics in clinical trials that employ Bayesian analysis and decision procedures relies on estimating the sampling distribution of posterior summaries via Monte Carlo simulation. It is computationally intensive to repeat this estimation process for each design configuration considered, particularly for clustered data that are analyzed using complex, high‐dimensional models. In this paper, we propose an efficient method to assess operating characteristics and determine sample sizes for Bayesian trials with clustered data. We prove theoretical results that enable posterior probabilities to be modeled as a function of the number of clusters. Using these functions, we assess operating characteristics at a range of sample sizes given simulations conducted at only two values for the number of clusters. These theoretical results are also leveraged to quantify the impact of simulation variability on our sample size recommendations. The applicability of our methodology is illustrated using an example Bayesian cluster‐randomized clinical trial.

SiM Testing & Uncertainty · 发表于 2026-03-12

Confidence Intervals for Comparing Two Independent Folded Normals: A Case Study in Bunion Surgery

Eleonora Di Carluccio, Sarah Ogutu, Ozkan Köse, Henry G. Mwambi, Andreas Ziegler

摘要

The absolute change in the angle measured immediately after surgery and after bone healing is a clinically relevant endpoint to judge the stability of an osteotomy. Assuming that the difference in angles is normally distributed, the absolute difference follows a folded normal distribution. The confidence interval (CI) for the absolute angle change of a novel fixation screw compared to a standard fixation screw may be used for evaluating non‐inferiority. We suggest that the Welch statistic may serve as the basis for CI calculations of the difference between two folded normals. The coverage probabilities of derived CIs are investigated by simulations. We illustrate the approaches with data from a randomized controlled trial and an observational study on bunion surgery, in which magnesium‐based and titanium‐based fixation screws were compared. In the simulation studies, asymptotic and both non‐parametric and parametric bootstrap CIs based on the Welch statistic were close to nominal coverage levels. In case of different sample sizes between groups, the t‐statistic‐based CIs were not always meeting the nominal coverage levels. Methods based on chi‐square distributions were not deemed appropriate for comparing two folded normals. The re‐analysis of the bunion trial permitted the conclusion of non‐inferiority for the primary endpoint, the absolute difference between baseline and six months follow‐up for the distal metatarsal articular angle, between magnesium‐based and titanium‐based fixation screws. We recommend the use of CIs based on the Welch statistic to evaluate non‐inferiority in trials where the stability of angles after osteotomy is to be compared.

SiM Causal Inference · 发表于 2026-03-11,收录于 2026-05-01

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials

Peter C. Austin

摘要

Propensity score methods allow researchers to mimic some (but not all) of the characteristics of a randomized controlled trial (RCT). Propensity score methods are usually applied to unstructured data, which allows one to mimic an RCT in which the individual is the unit of randomization. There is a small literature on how to use the propensity score with clustered data. However, these studies focused on settings in which the treatment is applied at the level of the individual, not to the cluster (thus there is within‐cluster variation in treatment received). Cluster randomization trials are RCTs in which intact clusters of individuals (i.e., primary care practices) are randomized to either treatment or control. There is a paucity of information on how to apply propensity score methods in observational studies in which individuals are nested in clusters, treatment is applied at the level of the cluster, and outcomes are assessed at the level of the individual. We described four strategies for using inverse probability of treatment weighting in such settings and evaluated their performance using simulations. While the propensity score is estimated as the level of the cluster (since treatment status does not vary within clusters), incorporating baseline individual‐level variables in the propensity score model (via computing cluster‐level means of these variables) or in the outcome linear regression model resulted in estimates with the lowest bias. Including the individual‐level baseline variable in the outcome linear model resulted in estimated treatment effects with the greatest precision and lowest mean squared error.

SiM Causal Inference High-Dimensional Nonparametric & Semiparametric · 发表于 2026-03-11,收录于 2026-05-01

Tuning LASSO Models for Propensity Score Weighting and Using Synthetic Negative Control Exposures for Residual Bias Detection

Richard Wyss, Ben B. Hansen, Georg Hahn, Lars van der Laan, Kueiyu Joshua Lin

摘要

The propensity score (PS) is widely used to control for large numbers of covariates in high‐dimensional healthcare database studies. In these settings, the least absolute shrinkage and selection operator (LASSO) is commonly used to estimate the PS, with the regularization parameter typically chosen by cross‐validation to optimize out‐of‐sample prediction. For PS weighting, however, theory and simulations have shown that prediction‐based tuning can over‐regularize the PS model and that less regularization (“undersmoothing”) is needed to minimize bias in PS weighted estimators. The optimal degree of undersmoothing can be guided by the efficient influence function of the target causal parameter. In practice, however, the efficient influence function is often unknown or difficult to derive. We therefore investigate balance metrics as a simple, broadly applicable approach for selecting the degree of undersmoothing when the efficient influence function is unavailable. Because balance‐based tuning does not guarantee minimal bias in PS weighted estimators—as such metrics are blind to the efficient influence function—we also propose a framework for generating synthetic negative control exposures for bias detection. We show that synthetic negative control exposures can identify analyses that likely violate partial exchangeability due to inadequate control for measured confounding. In numerical studies, balance‐based undersmoothing consistently reduced bias relative to standard cross‐validation, while synthetic negative control exposures effectively flagged analyses with residual confounding. Together, these approaches provide practical tools for improving PS weighting analyses when theory‐driven tuning is infeasible.

SiM Survival Analysis · 发表于 2026-03-11,收录于 2026-05-01

Time‐Varying Hormonal Treatment and Metastasis‐Free Survival Among ER+ Breast Cancer Patients: A Natural History Modelling Approach

Letizia Orsini, Alessandro Gasparini, Kamila Czene, Keith Humphreys

摘要

Breast cancer treatment depends on tumour subtypes. In particular, patients with oestrogen receptor‐positive (ER+) tumours are treated with hormonal therapy. In Sweden, the recommended treatment duration is five years, with current guidelines advising an additional five years for women at high risk of disease recurrence. However, the impact of extended therapy on metastatic progression has not been thoroughly quantified at the population level. In this article, we use a modelling approach to estimate the time‐varying effect of hormonal treatment on time to metastasis. The model is then used to compare 5‐ and 10‐year treatment durations at different tumour sizes. Rather than using a common statistical modelling approach, we incorporate the effect of endocrine therapy within a biologically inspired natural history model of breast cancer to accommodate key features of the expected treatment‐outcome relationship. We fitted the model using maximum likelihood and data from a cohort of 9,716 incident cases diagnosed with invasive ER+ breast cancer between 2005 and 2020. Based on our main model estimates, the 10‐year metastasis‐free survival would improve from 92.8% to 96.1% for a symptomatic patient with a 20 mm tumour with ten years (instead of five) of hormonal treatment. Our natural history model quantifies the impact of prolonged hormonal treatment on metastatic events in ER+ breast cancer patients, including features that are not captured by traditional statistical approaches. Results suggest a significant reduction in metastatic tumour growth rates during treatment, supporting the extension of endocrine therapy to 10 years for people with large tumours.

SiM Causal Inference Missing Data & Measurement Error Survival Analysis · 发表于 2026-03-11,收录于 2026-05-01

Missingness in Eligibility Criteria for Target Trial Emulation in EHR With Survival Outcomes

Jenny Shen, Kristin A. Linn, Amy S. Clark, Ronac Mamtani, Rebecca A. Hubbard

摘要

In certain settings, when conducting a randomized trial would be infeasible, electronic health records (EHR) can be used to emulate a target trial and estimate causal effects of an intervention. This process involves specifying the elements of a hypothetical trial protocol and applying these to the design of an observational study conducted with EHR data (or other observational data source). One element of target trial specification includes defining eligibility criteria. However, defining the eligible population with EHR can be complicated by missingness in eligibility‐defining variables. Multiple imputation (MI) is one common approach to missingness in EHR data, but it is unclear whether imputation of eligibility criteria should occur before or after excluding ineligible individuals. Motivated by a target trial emulation of two treatments for advanced breast cancer, we explore this question when estimating the average causal effect under a target trial framework with survival outcomes. We illustrate how alternative MI strategies perform using simulated data and in a real‐world analysis of oncology EHR data. We found that in most settings with high proportions of missingness in eligibility‐defining variables, imputing missing data using a flexible imputation model, such as a random forest, prior to excluding ineligible individuals resulted in lower bias than complete case analysis or imputation after excluding ineligible individuals. Choices about how to handle practical challenges such as this in the application of target trial emulation to messy, real‐world data sources can have substantial effects on causal parameter estimation and should be carefully considered to ensure that the results of observational studies are as rigorous as possible.

SiM Longitudinal Data · 发表于 2026-03-10

Two‐Part Hidden Semi‐Markov Mixed Effects Models for Semi‐Continuous Longitudinal Data

Yibo Long, Jiaqing Chen, Xueqiang Ye, Yangxin Huang

摘要

Modeling dynamic heterogeneity is essential for revealing the distinct longitudinal trajectories of individual change. Dynamic heterogeneity analysis of semi‐continuous longitudinal data is commonly difficult due to the semi‐continuity of longitudinal responses. The hidden semi‐Markov model is a powerful tool that can reveal the longitudinal dependency structure and the dynamic heterogeneity of the observation process by introducing the sojourn time distribution. To address the challenge of modeling dynamic heterogeneity in semi‐continuous longitudinal data, this study develops a two‐part hidden semi‐Markov mixed‐effects model. The proposed model mainly consists of two parts: a discrete binary indicator model to estimate the probability of a zero outcome for the semi‐continuous longitudinal response, and a continuous hidden semi‐Markov model to fit the positive values of semi‐continuous longitudinal responses. In order to accurately obtain the state of each individual at different observation times, a set of likelihood ratio test state iteration algorithms is developed. Bayesian methods are used to estimate the regression coefficients and state parameters of the proposed model. The proposed methodology is applied to analyze the dataset of the Health and Retirement Study conducted by the University of Michigan. Simulation studies are conducted to assess the flexibility of the proposed model under various scenarios.

Biometrics Networks & Graphs Testing & Uncertainty Latent Variables & Mixtures · 发表于 2026-03-10

Inference for microbe–metabolite association networks using a latent graph model

Jing Ma

摘要

Correlation networks are commonly used to infer associations between microbes and metabolites. The resulting $p$-values are then corrected for multiple comparisons using existing methods such as the Benjamini & Hochberg (BH) procedure to control the false discovery rate (FDR). However, most existing methods for FDR control assume the $p$-values are weakly dependent. Consequently, they can have low power in recovering microbe–metabolite association networks that exhibit important topological features, such as the presence of densely associated modules. We propose a novel inference procedure that is both powerful for detecting significant associations in the microbe–metabolite network and capable of controlling the FDR. Power enhancement is achieved by modeling latent structures in the form of a bipartite stochastic block model. We develop a variational expectation–maximization (EM) algorithm to estimate the model parameters and incorporate the learned graph in the testing procedure. In addition to FDR control, this procedure provides a clustering of microbes and metabolites into modules, which is useful for interpretation. We demonstrate the merit of the proposed method in simulations and an application to bacterial vaginosis.

Biometrika Causal Inference High-Dimensional · 发表于 2026-03-10

Dynamic covariate balancing: estimating treatment effects over time with potential local projections

Davide Viviano, Jelena Bradic

摘要

This article concerns the estimation and inference of treatment effects in panel data settings when treatments change dynamically over time. We propose a balancing method that allows for (i) treatments to be assigned dynamically over time based on high-dimensional covariates, past outcomes and treatments; (ii) outcomes and time-varying covariates to depend on the trajectory of all past treatments; and (iii) heterogeneity of treatment effects. Our approach recursively projects potential outcomes’ expectations on past histories. It then controls the bias arising from the nonexperimental and sequential nature of this setting by balancing dynamically observable characteristics over time. We establish inferential guarantees for the proposed method even in cases where the number of observable characteristics greatly exceeds the sample size. We study numerical properties of the estimator and illustrate the advantages of the procedure in an empirical application.

JRSSB Causal Inference Networks & Graphs · 发表于 2026-03-09

The causal effects of modified treatment policies under network interference

Salvador V Balkus, Scott W Delaney, Nima S Hejazi

摘要

Modified treatment policies are a widely applicable class of interventions useful for studying the causal effects of continuous exposures. Approaches to evaluating their causal effects assume no interference, meaning that such effects cannot be learned from data in settings where the exposure of one unit affects the outcomes of others, as is common in spatial or network data. We introduce a new class of intervention—induced modified treatment policies—which we show identify such causal effects in the presence of network interference. Building on recent developments for causal inference in networks, we provide flexible, semi-parametric efficient estimators of the statistical estimand. Numerical experiments demonstrate that an induced modified treatment policy can eliminate the causal, or identification, bias that results from network interference. We use the methodology developed to evaluate the effect of zero-emission vehicle uptake on air pollution in California, strengthening prior evidence.

SiM Other · 发表于 2026-03-09

Testing and Quantifying Site‐Level Variability in Diagnostic Sensitivity of an Anchor Variable

Seungchul Baek, Yanyuan Ma, Tanya P. Garcia

摘要

In multi‐site clinical research, diagnostic assessments can vary across sites even when standardized criteria and instruments are used, leading to inconsistent disease classification. This issue is examined in settings with an anchor variable that confidently identifies disease when positive but provides no information when negative. A random effects model is introduced for site‐specific sensitivity, along with likelihood‐based methods for estimation and hypothesis testing. The approach addresses two objectives: testing whether diagnostic sensitivity varies across sites, and quantifying the magnitude of such variability. Validation data is incorporated to establish parameter identifiability. Laplace approximation and the Expectation‐Maximization (EM) algorithm are further engaged to address the computational challenge caused by an intractable integral in the likelihood function. Likelihood ratio and score tests are constructed to account for the boundary constraint that arises when the null hypothesis places the variance component at zero. Simulation studies demonstrate the good performance in finite samples, with accurate parameter estimates and appropriate test size and power. Application to a multi‐site Huntington disease cohort for diagnosing mild cognitive impairment reveals differences in diagnostic sensitivity across sites, with tests providing strong evidence of heterogeneity. This framework offers a principled approach for testing and quantifying site‐level variability in diagnostic sensitivity, supporting more consistent inference in multi‐site studies.

SiM Survival Analysis · 发表于 2026-03-09

Predicting Individual Risk of Advanced Adenoma Based on the Interval‐Censored Recurrent Adenoma Event and Informative Screening Time

Yipeng Wei, May AlHusseini, Hormuzd A. Katki, Rajeshwari Sundaram, Qing Pan

SiM Missing Data & Measurement Error · 发表于 2026-03-09

Generalized SIMEX Method: Polynomial Approximation for Extrapolation

Li‐Pang Chen, Qihuang Zhang

摘要

Measurement error is a common challenge in statistical analysis, often leading to incorrect parameter estimation. To address measurement error effects, the simulation and extrapolation (SIMEX) method is one of the widely used approaches because of its flexibility in model specification and generic scope of application. Key concerns of the SIMEX method include the number of repetitions in generating synthetic data and the choice of extrapolation function to recover the corrected estimates from the error‐prone ones. In most of the existing developments, the quadratic function is frequently adopted as the extrapolation function. However, when measurement error effects are tremendously severe, quadratic functions may be suboptimal. In addition, the development of theoretical results of existing methods requires an unrealistic assumption that the true extrapolation function is known. To address those concerns, we propose GSIMEX, extending the SIMEX method by considering a higher‐order polynomial function as the extrapolation function, which enables us to approximate the unknown and nonlinear extrapolation function. In addition, to improve the accuracy of the corrected estimator, we integrate subset selection and model averaging strategies. The theoretical results of GSIMEX, including the measurement of the approximation and asymptotic normality of the estimator, are rigorously established. Numerical studies are conducted for justification of validation, which show that GSIMEX is valid for dealing with severe measurement error effects and is flexible in handling different types of data structures and regression models. We analyze the simulated and spatial transcriptomics data to illustrate the usage of GSIMEX.

SiM Clinical Trials Causal Inference · 发表于 2026-03-09,收录于 2026-05-01

Comparing HIV Vaccine Immunogenicity Across Trials With Different Populations and Study Designs

Yutong Jin, Alex Luedtke, Zoe Moodie, Holly Janes, David Benkeser

摘要

Safe and effective preventive vaccines have the potential to help stem the HIV epidemic. The efficacy of such vaccines is typically measured in randomized, double‐blind phase IIb/III trials and described as a reduction in newly acquired HIV infections. However, such trials are often expensive, time‐consuming, and/or logistically challenging. These challenges lead to a great interest in immune responses induced by vaccination, and in identifying which immune responses predict vaccine efficacy. These responses are termed vaccine correlates of protection . Studies of vaccine‐induced immunogenicity vary in size and design, ranging from small, early‐phase trials to case‐control studies nested in a broader late‐phase randomized trial. Moreover, trials can be conducted in geographically diverse study populations across the world. Such diversity presents a challenge for objectively comparing vaccine‐induced immunogenicity. To address these practical challenges, we propose a framework that is capable of identifying appropriate causal estimands and estimators, which can be used to provide standardized comparisons of vaccine‐induced immunogenicity across trials. We evaluate the performance of the proposed estimands via extensive simulation studies. Our estimators are well‐behaved and enjoy robustness properties. The proposed technique is applied to compare vaccine immunogenicity using data from three recent HIV vaccine trials.

Biometrics Nonparametric & Semiparametric High-Dimensional · 发表于 2026-03-06

Reduced varying coefficient models for regional quantile regression with multiple responses

Woorim Jung, Seyoung Park, Hyokyoung G Hong, Eun Ryung Lee

摘要

Analyzing multiple outcome variables via regional quantile regression in high-dimensional settings poses significant statistical and computational challenges. In this paper, we propose a new framework that models multivariate quantile varying coefficients using principal component functions, enforcing a low-rank structure on the coefficient matrix to achieve parsimony and interpretability. Our approach augments this representation with a KNN-fused LASSO penalty to capture shared dynamic patterns and identify latent clusters within the principal components. Through comprehensive simulation studies, we demonstrate that our method consistently provides accurate estimates and robust performance under various high-dimensional scenarios. We further illustrate its practical utility with two real-world health datasets, where our approach uncovers complex, quantile-specific associations between predictors and multiple correlated outcomes across a time index.

Biometrics Other · 发表于 2026-03-06

OPERA: a new algorithm for patient stratification based on partially ordered risk factors

Yingzhou Liu, Menggang Yu

摘要

Risk stratification is an invaluable tool for modern healthcare systems. By separating patients into subgroups with distinct disease severity and prognosis, it allows better clinical decision making due to targeted care thus ultimately fosters healthier patient populations. For example, the American Joint Committee on Cancer staging is an indispensible first step for any cancer care. Based on the stages, appropriate treatments are given to optimize clinical outcomes such as recurrence free survival or overall survival. Consequently, it enhances communication, engagement, and research focus. This paper presents a new algorithm entitled ‘Ordering Poset Elements by Recursive Amalgamation’ (OPERA) for patient stratification using many risk factors. Health risk factors frequently exhibit total or partial ordering and when considered jointly, they form a partially ordered set or a poset. Compared with the usual regression models, OPERA can explore high order interactions similar to the well-known tree method. On the other hand, by explicitly exploring the poset structure, OPERA allows flexible staging patterns and faster pruning for better performance. OPERA is evaluated in extensive simulation studies and cancer staging data to demonstrate its ability in performing risk stratification using ordered risk factors.

Biometrics Meta-Analysis & Data Integration Causal Inference · 发表于 2026-03-05

Distributed fusion R -learner of heterogeneous treatment effect using distributed medicaid data

Jinhong Li, Julie M Donohue, Lu Tang

摘要

Interest in data-driven decision-making has stimulated method developments in estimating heterogeneous treatment effect. In practice, accurately estimating a conditional average treatment effect (CATE) requires a large sample, which is often realized by data integration that leverages information from multiple data sites. This paper attempts to address two challenges involved in such task, treatment effect heterogeneity and privacy protection. The first pertains to differences in the CATE coefficient across sites due to heterogeneity in treatment effect; the second pertains to barriers in sharing sensitive data across sites. We propose a distributed fusion learning approach, DF $R$-learner, to jointly estimate CATE across sites without pooling individual-participant data. It allows the CATE functions to differ and uses a data-driven fusion penalty to combine similar parameters across sites in achieving improved estimation. The estimator uses confidence distributions to facilitate efficiency and private information exchange, which we show theoretically and empirically no loss of efficiency compared to its counterpart based on centralized data. We examine DF $R$-learner through a study of medication treatment for opioid use disorder using distributed Medicaid data from multiple managed care organizations within the state of Pennsylvania.

SMMR Survival Analysis Latent Variables & Mixtures · 发表于 2026-03-04

Regression analysis of interval-censored competing risks data with missing causes of failure: A direct likelihood approach

Yichen Lou, Yuqing Ma, Liming Xiang, Jianguo Sun

摘要

Regression analysis of interval-censored competing risks data is often required and plays an important role in many areas. For the situation, in addition to competing risk and interval censoring, another feature that makes the analysis difficult is that the failure cause may be unknown or missing. Most existing methods for addressing these challenges rely on two-stage estimation procedures, which could suffer efficiency loss and high computational cost. To overcome these, we propose a direct likelihood approach based on a mixture model framework. The proposed method accounts for both competing risks and missingness of event types directly in a likelihood function and facilitates estimation through a sieve maximum likelihood estimation, simplifying the estimation procedure and thus enhancing the estimation efficiency. The consistency and asymptotic normality of the resulting estimators are established, and the idea behind the proposed approach can be extended to other competing risks model frameworks. We demonstrate the promising performance of the proposed method in a comprehensive simulation study and illustrate its practical utility with an application to an Alzheimer’s disease study.

SiM Clinical Trials Bayesian Methods · 发表于 2026-03-04

Bayesian Ordered Lattice Design for Phase I Clinical Trials

Gi‐Ming Wang, Curtis Tatsuoka

摘要

We develop a new framework specifically for early Phase I clinical trials called Bayesian Ordered Lattice Design (BOLD). This study is motivated by two key factors. First, Phase I clinical trials typically involve relatively small sample sizes, which can make the use of prior information on dose‐limiting toxicity (DLT) rates highly significant. To address this challenge, the proposed Bayesian methodology incorporates prior information and posterior updating to guide dose selection, toxicity monitoring, early stopping, and identification of the maximum tolerable dose (MTD). Second, a natural ordering among toxicity probabilities across different dose levels can be utilized, with the idea being that analysis of dose‐level posterior probabilities can and should acquire insights from data obtained at other dose levels, by leveraging their order relationship. Our proposed approach employs straightforward dose‐level Bayesian specifications and relies on intuitive and clinically interpretable DLT rate posterior probabilities for decision‐making. Importantly, we show that it can often outperform popular methods in terms of accuracy in determining the MTD. This Bayesian approach is also computationally simple and avoids simulation.

SiM Survival Analysis · 发表于 2026-03-03

Using Quadratic Programming to Reconstruct Data From Published Survival and Competing Risks Analyses

Andrew C. Titman

摘要

The ability to retrieve pseudo‐individual patient data (IPD) from published survival study results is important to facilitate meta‐analysis, evidence synthesis or secondary data analyses for the purpose of decision modeling for cost effectiveness analysis. While established methods exist for retrieving pseudo‐IPD from Kaplan–Meier plots, these algorithms are not easily extendable to other types of survival data, nor do they allow all available information to be incorporated. An optimization‐based approach is proposed where the task of reconstructing the IPD is formulated as a quadratic program (QP) with linear constraints. The method easily allows auxiliary information such as marked censoring times. Moreover, the same approach can be used to reconstruct patient‐level competing risks survival data from published cumulative incidence functions. In simulation, the QP‐based method is shown to outperform existing algorithms particularly when data on numbers at risk and marked censoring times are available. The methods are illustrated through reconstruction of data from a published study on patients with advanced stage follicular lymphoma.

SiM Bayesian Methods Latent Variables & Mixtures · 发表于 2026-03-03

Personalized Nutrition Recommendations Using a Bayesian Mixture Model of Concentration Constraints and Intake Preferences

Jari Turkia, Ursula Schwab, Ville Hautamäki

摘要

Maintaining proper nutrition is crucial for preserving health and preventing disease. However, what constitutes proper nutrition may vary among individuals; evidence indicates that the effects of diet and even single nutrients can differ considerably because of personal characteristics. This personal variability can be observed through blood markers, such as concentrations of plasma cholesterol and insulin, and captured using a hierarchical multivariate model. We leverage this variability and propose a conditional two‐component Bayesian mixture model for generating personalized diet recommendations. The model uses the Nordic Nutrition Recommendations 2023 as a prior for healthy intake and infers individualized recommendations as posterior distributions. The first component identifies dietary options predicted to produce healthy levels across all considered blood markers, while the second selects, among these valid options, the diet closest to predefined personal preferences. The preference component is configurable and, in this study, was used to minimize dietary adjustments to support recommendation adherence while providing well‐defined targets for nutrients less critical to concentration regulation. The method was evaluated using nutritional data from two studies: one in prediabetic individuals and one in patients with kidney dysfunction. Numerical simulations showed that the individualized diets could restore or approach normal plasma concentrations when the estimated personal nutrient effects indicated biological feasibility. As the results align with current nutritional literature, the Bayesian approach offers a principled way to leverage observational nutrition data. However, future clinical studies are needed to validate the results and modeling approach before these can be translated into evidence‐based personalized nutritional counseling.

SMMR Longitudinal Data · 发表于 2026-03-03

Likelihood ratio test for the disease progression model to measure saved time in Alzheimer’s disease

Guogen Shan, Yahui Zhang, Zhixin Tang, Aidong Adam Ding

摘要

Saved time provides an intuitive interpretation comparing a new treatment to the placebo in a randomized trial with repeated measures. The projection approach is frequently used to estimate saved time by using the placebo group disease progression curve and the last visit data from the treatment group. Disease modifying therapies for Alzheimer’s disease (AD) are expected to slow disease progression. For that reason, several disease progression models were developed to assess the effectiveness of the new treatment. These models require patient level data which are often challenging to obtain. Therefore, we propose to develop a likelihood ratio (LR) test to assess whether a new treatment can delay disease progression in time (e.g. proportional time delayed over the course of a trial) as compared to the placebo, by using the summary statistics from the published results instead of patient level data. We compare the performance of the LR test and the existing tests with regard to type I error rate and statistical power. The proposed LR test is often more powerful than the existing Wald type test when the placebo group has slower disease progression rates in later visits. We then use the summary statistics from the recent donanemab phase 3 trial to illustrate the application of the proposed LR test.

SMMR Survival Analysis · 发表于 2026-03-03

Improved survival analysis with shrinkage Kibria–Lukman estimators in the Cox model: Application to lung cancer data

Solmaz Seifollahi, Mohammad Arashi

摘要

The Cox proportional hazards regression model is a widely used and valuable tool for modeling survival time with predictors, however its performance can deteriorate in the presence of multicollinearity. It can lead to unreliable estimates from the maximum partial likelihood estimator. In this paper, we introduce enhanced shrinkage estimators based on the Kibria–Lukman approach to obtain more efficient coefficient estimates. Specifically, we develop linear shrinkage, Stein and its positive counterpart, pretest, and shrinkage pretest estimators that incorporate prior information about model coefficients. We derive their asymptotic bias and variance properties and evaluate their performance through extensive Monte Carlo simulations. The results demonstrate significant improvements, highlighting the practical advantages of these methods for applied researchers. We also illustrate the application of our proposed estimators using a lung cancer dataset.

Biometrika High-Dimensional Bayesian Methods · 发表于 2026-03-03

Diaconis–Ylvisaker prior penalized likelihood for $ p/n\to\kappa\in(0,1) $ logistic regression

P Sterzinger, I Kosmidis

摘要

Summary: We characterize the behaviour of the maximum Diaconis–Ylvisaker prior penalized likelihood estimator in high-dimensional logistic regression, where the number of covariates is a fraction $ \kappa\in(0,1) $ of the number of observations $ n $, as $ n\to\infty $. We construct a rescaled estimator with zero asymptotic aggregate bias, and define adjusted $ Z $-statistics and rescaled penalized likelihood ratio statistics that exhibit the typical null asymptotic distributions, when the covariates are independent multivariate normal with an arbitrary covariance matrix and the linear predictor has asymptotic variance $ \gamma^{2} $. While the maximum likelihood estimate asymptotically exists only for a narrow range of $ (\kappa,\gamma) $ values, the maximum Diaconis–Ylvisaker prior penalized likelihood estimate always exists and can be computed directly using standard maximum likelihood routines. Thus, our asymptotic results extend to $ (\kappa,\gamma) $ values for which the maximum likelihood framework breaks down, with no additional implementation or computational cost. We study the estimator’s shrinkage properties, compare the proposed estimation and inference procedures with alternatives that also accommodate proportional asymptotics, and formulate a conjecture, supported by strong empirical evidence, that extends our results to models including an intercept parameter. Finally, we propose estimation methods for all unknown constants involved in our procedures and demonstrate the theoretical advances through extensive simulation studies and the analysis of digit recognition data.

Biometrika Other · 发表于 2026-03-03

Characterizing extremal dependence on a hyperplane

P Wan

摘要

Summary: In this paper, we characterize the extremal dependence of $ d $ asymptotically dependent variables using a class of random vectors on the $ (d-1) $-dimensional hyperplane perpendicular to the diagonal vector $ \mathbf{1}=(1,\ldots,1) $. This translates analyses of multivariate extremes to analyses on a linear vector space, opening up possibilities for applying existing statistical techniques based on linear operations. As an example, we demonstrate how to obtain lower-dimensional approximations of tail dependence through principal component analysis. Additionally, we show that the widely used Hüsler–Reiss family is characterized by a Gaussian family residing on the hyperplane.

SiM Latent Variables & Mixtures Bayesian Methods · 发表于 2026-03-03

Bayesian Tensor Decomposition for Clustering Latent Symptom Profiles for Verbal Autopsy Data

Yu Zhu, Zehang Richard Li

摘要

Cause‐of‐death data is fundamental for understanding population health trends and inequalities as well as designing and evaluating public health interventions. A significant proportion of global deaths, particularly in low‐ and middle‐income countries (LMICs), do not have medically certified causes assigned. In such settings, verbal autopsy (VA) is a widely adopted approach to estimate disease burdens by interviewing caregivers of the deceased. Recently, latent class models have been developed to model the joint distribution of symptoms and perform probabilistic cause‐of‐death assignment. A large number of latent classes are usually needed in order to characterize the complex dependence among symptoms, making the estimated symptom profiles challenging to summarize and interpret. In this paper, we propose a flexible Bayesian tensor decomposition framework that balances the predictive accuracy of the cause‐of‐death assignment task and the interpretability of the latent structures. The key to our approach is to partition symptoms into groups and model the joint distributions of group‐level symptom sub‐profiles. The proposed methods achieve better predictive accuracy than existing VA methods and provide a more parsimonious representation of the symptom distributions. We show our methods provide new insights into the clustering patterns of both symptoms and causes using the PHMRC gold‐standard VA dataset.

SMMR Other · 发表于 2026-03-03

An ensemble approach to tensor learning

Jiaxin He, Jialiang Li

摘要

Motivated by recent development of tensor regression modeling, we propose a novel tensor ensemble learning (TEL) approach. While CANDECOMP/PARAFAC (CP) decomposition is an efficient technique to reduce the number of parameters in tensor covariate, determining an appropriate CP rank remains uncertain in practice. Furthermore, the structural complexity of tensor often varies across different spatial regions. To explore the intrinsic tensor structure, we design different tensor partition strategies and divide tensor into disjoint blocks to form candidate models. A model ensemble method is then developed to explore the uncertainty in both tensor block structure and CP rank. To assign weights to candidate models and enhance predictive performance, we leverage the predictability, computability, and stability framework for veridical data science. Simulation studies are carried out to assess the performance of TEL under varying levels of tensor complexity. We further apply TEL to two real data applications about glaucoma management using fundus image and cognitive ability prediction in Alzheimer’s disease using neuroimaging. Our numerical studies illustrate the superiority of TEL over existing methods and highlight its promise for complex tensor data analysis.

第 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 页